1. Home
  2. ARVN vs CSIQ Comparison

ARVN vs CSIQ Comparison

Compare ARVN & CSIQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arvinas Inc.

ARVN

Arvinas Inc.

N/A

Current Price

$6.79

Market Cap

600.2M

Sector

Health Care

ML Signal

N/A

Logo Canadian Solar Inc. (ON)

CSIQ

Canadian Solar Inc. (ON)

N/A

Current Price

$9.83

Market Cap

681.7M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ARVN
CSIQ
Founded
2015
2001
Country
United States
Canada
Employees
N/A
12587
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
600.2M
681.7M
IPO Year
2018
2006

Fundamental Metrics

Financial Performance
Metric
ARVN
CSIQ
Price
$6.79
$9.83
Analyst Decision
Buy
Hold
Analyst Count
15
12
Target Price
$14.00
★ $16.93
AVG Volume (30 Days)
859.5K
★ 2.1M
Earning Date
11-03-2026
12-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 58.84
N/A
EPS
★ 0.88
N/A
Revenue
★ $262,600,000.00
N/A
Revenue This Year
$5.67
N/A
Revenue Next Year
N/A
$26.35
P/E Ratio
$7.78
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$6.33
$8.79
52 Week High
$14.22
$31.79

Technical Indicators

Market Signals
Indicator
ARVN
CSIQ
Relative Strength Index (RSI) 41.87 44.94
Support Level $6.74 $8.79
Resistance Level $7.85 $16.48
Average True Range (ATR) 0.47 0.73
MACD -0.03 0.10
Stochastic Oscillator 27.06 34.79

Price Performance

Historical Comparison
ARVN
CSIQ

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

About CSIQ Canadian Solar Inc. (ON)

Canadian Solar Inc is a Canadian solar technology and renewable energy company. It is a manufacturer of solar photovoltaic modules, a provider of battery energy storage solutions, and a developer of utility-scale solar power and battery energy storage projects. The company is organized in two segments: Manufacturing segment, comprising CS PowerTech, which focuses on manufacturing and sales of solar products, battery energy storage products, and other power technology products for the U.S. market and CSI Solar, which serves all other world-wide markets; and Recurrent Energy segment, which focuses on solar power and battery storage project development, asset sales, power services, and electricity revenue from its operating portfolio. It derives maximum revenue from Manufacturing segment.

Share on Social Networks: